Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
companyunderground
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Innate shares crushed on second big setback for Bristol-Myers partnered lirilumab
Innate shares crushed on second big setback for Bristol-Myers partnered lirilumab
Innate shares crushed on second big setback for Bristol-Myers partnered lirilumab
Submitted by
admin
on November 25, 2017 - 12:32pm
Source:
Endpoints
News Tags:
Innate Pharma
Bristol-Myers Squibb
lirilumab
acute myeloid leukemia
Headline:
Innate shares crushed on second big setback for Bristol-Myers partnered lirilumab
Do Not Allow Advertisers to Use My Personal information
